EMVision Medical Devices (ASX:EMV) said it has started the process of activating the Liverpool Hospital in Sydney for the trial of its emu bedside brain scanner this week, with Mount Sinai Hospital in New York set to follow later this month, according to a Tuesday filing with the Australian bourse.
The two new sites bring the total number of activated trial locations to five, with a sixth site expected to join shortly, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.